M&A Deal Summary

Catalent Acquires MaSTherCell SA

On February 3, 2020, Catalent, Inc. acquired life science company MaSTherCell SA from Great Point Partners and Orgenesis, Inc. for 315M USD

Acquisition Highlights
  • This is Catalent’s 6th transaction in the Life Science sector.
  • This is Catalent’s 4th largest (disclosed) transaction.
  • This is Catalent’s 1st transaction in Belgium.

M&A Deal Summary

Date 2020-02-03
Target MaSTherCell SA
Sector Life Science
Buyer(s) Catalent, Inc.
Sellers(s) Great Point Partners
Orgenesis, Inc.
Deal Type Divestiture
Deal Value 315M USD

Target

MaSTherCell SA

Gosselies, Belgium
website
MaSTherCell SA (Manufacturing Synergies for Therapeutic Cells) is a technology-driven, customer-oriented Contract Development and Manufacturing Organization (CDMO) specialized in cell therapy development for advanced medicinal products. MaSTherCell was established in 2011 and is based in Gosselies, Belgium.

Search 163,065 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Catalent, Inc.

Somerset, New Jersey, United States

website


Category Company
Founded 2007
SectorLife Science
Employees14,000
Revenue 3.1B USD (2020)
DESCRIPTION

Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey.


DEAL STATS #
Overall 10 of 15
Sector (Life Science) 6 of 9
Type (Divestiture) 2 of 5
Country (Belgium) 1 of 3
Year (2020) 1 of 3
Size (of disclosed) 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-19 Bristol-Myers Squibb Co. - Anagni Manufacturing Facility

Anagni, Italy

Bristol-Myers Squibb Co. - Anagni Manufacturing Facility is a provider of oral solid, biologics, and sterile product manufacturing and packaging facility.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-21 Teva Takeda Pharma Ltd. - Clinical Packaging Facility

Minakuchi, Japan

Teva Takeda Pharma Ltd. - Clinical Packaging Facility is a clinical GMP manufacturing and distribution hub that supports clinical studies. The 60,000-square-foot facility provides demand-led supply services, primary and secondary packaging capabilities, a range of temperature options for storage and distribution, as well as clinical returns and destruction services.

Buy -

Seller(S) 2

SELLER

Great Point Partners

Greenwich, Connecticut, United States

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 2003
PE ASSETS 456M USD
SizeMiddle-Market
Type Sector Focused
DESCRIPTION

Great Point Partners is a private investment firm focused on investing in private and public healthcare companies. Great Point's private equity practice invests $7 to $25 million of growth capital in private, growing companies. Specific areas of interest within the healthcare sector includes biotechnology and life sciences, consumer health, generic drugs, health care services, information technology, insurance, medical devices, specialty pharmaceuticals, and worker compensation companies. Great Point Partners was formed in 2003 and is based in Greenwich, Connecticut.


DEAL STATS #
Overall 12 of 15
Sector (Life Science) 6 of 7
Type (Divestiture) 1 of 1
Country (Belgium) 1 of 1
Year (2020) 1 of 2
Size (of disclosed) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-19 CorEvitas LLC

Waltham, Massachusetts, United States

CorEvitas provides real-world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators. Corona operates six major autoimmune registries across the US, Canada, and Japan, collecting data from over 500 participating investigator sites. CorEvitas was founded in 2001 and is based in Waltham, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-25 Citra Health Solutions, Inc.

Jacksonville, Florida, United States

Citra Health Solutions, Inc. is a provider of capitation management software solutions. Citra Health Solutions is based in Jacksonville, Florida.

Sell -
SELLER

Orgenesis, Inc.

Germantown, Maryland, United States

website


Category Company
Founded 2008
SectorLife Science
Employees111
Revenue 8M USD (2020)
DESCRIPTION

Orgenesis is a pre-clinical cell therapy and regenerative medicine company that is committed to curing Type 1 Diabetes. Orgenesis was founded in 2008 and is based in Germantown, Maryland.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (Belgium) 1 of 1
Year (2020) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-03-09 MaSTherCell SA

Gosselies, Belgium

MaSTherCell SA (Manufacturing Synergies for Therapeutic Cells) is a technology-driven, customer-oriented Contract Development and Manufacturing Organization (CDMO) specialized in cell therapy development for advanced medicinal products. MaSTherCell was established in 2011 and is based in Gosselies, Belgium.

Buy $25M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-09-29 Koligo Therapeutics, Inc.

New Albany, Indiana, United States

Koligo Therapeutics, Inc. is a regenerative medicine company that develops, manufacture, and commercializes transformative cell therapies for the treatment of pancreatic diseases.

Buy -